Home » Newsletters » BioWorld

BioWorld

March 14, 2000

View Archived Issues

Other News To Note

Avax Raises $25M Privately To Advance Cancer Vaccines

Cubist Proposes Offering To Bring In $128M For Programs

Geron Seeks $175M In Offering To Advance Three Programs

Patent Disclosures

Visible Genetics Seeks $186M For Pharmacogenomics Work

Chirons FGF-2 Reduces Angina, But Fails With Primary Endpoint

GeneTrace Acquires Strata, Pushes Modular Research

Column Allows Characterization Of Cancer Antibodies Elicited By Complex Carbohydrate Vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...